U-Screen Dx Overview
- Founded
- 2013

- Status
- Out of Business
- Employees
- 4

- Latest Deal Type
- Out of Business
U-Screen Dx General Information
Description
Developer of cancer screening tests designed to detect cancer in the early stage. The company's tests is an early-stage biotech enterprise developing screening tests focused on infection-related cancers such as hepatitis B virus (HBV)-induced liver cancer, enabling doctors to accurately and simultaneously detect both genetic and epigenetic circulating DNA markers in urine and blood.
Contact Information
- 3805 Old Easton Road
- Doylestown, PA 18902
- United States
U-Screen Dx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 28-Nov-2020 | Completed | Out of Business | |||
2. Grant | 01-Jan-2015 | 00000 | Completed | Generating Revenue | ||
1. Accelerator/Incubator | 11-Jul-2014 | Completed | Generating Revenue |
U-Screen Dx Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial